Multiplexed Assays Go Digital at the Biodetection Technologies 2010 Conference

Applied BioCode Presents "Multiplexed Assays Go Digital" at the Biodetection Technologies 2010 Conference in Arlington, Virginia.

SANTA FE SPRINGS, Calif.--()--Applied BioCode, Inc. announced today a presentation to be given on their Barcoded Magnetic Beads technology at the Biodetection Technologies 2010 Conference in Arlington, Virginia. The presentation is titled “Multiplexed Assays Go Digital” and will be given by Dr. Winston Ho, President at Applied BioCode, on June 18, 2010.

The “Multiplexed Assays Go Digital” presentation focuses on the company’s novel Barcoded Magnetic Beads (BMB) Technology which utilizes a digital technology and offers unmatched decoding accuracy in addition to precise fluorescence detection. The polymer-based BMB’s are permanently encoded with a paramagnetic material which provides an accurate digital pattern and also allows for easy washing, separation and automation. The digital pattern is scalable and to date Barcoded Magnetic Beads with 32, 128 and 1,024-plex codes have been mass produced.

Applied BioCode’s Barcoded Magnetic Beads technology, along with the BioCode-1000 BMB Analyzer for barcode and fluorescence detection, results in an extremely flexible platform suited for those focused on a wide variety of applications using multiplexed assays, such as clinical diagnostics, gene mutation analysis, drug resistance genotyping, pharmaceutical drug discovery, and biodetection.

The BioCode-1000 Analyzer is a rapid, simple, and robust BMB imaging system for a 96-well microplate format. The system is used to detect from 2 to 128-plex Nucleic Acid or Protein targets in individual microwells. The system can scan a 96-well microplate, decode barcodes, measure label fluorescence, and display results in only 40 seconds per microwell. The system is extremely sensitive (0.5 fm/ml GAPDH (DNA) and 1.0 pg/ml IL-2 (protein) with PE label) and has been used for a variety of panel tests. The Biocode-1000 BMB Analyzer simplifies the testing of multiplexed assays while offering high throughput, high accuracy, and affordability.

Applied BioCode is a privately held biotechnology company with headquarters located in Santa Fe Springs, California. Applied BioCode develops, manufactures, and markets highly multiplexed products to assist those focused on the molecular diagnostics, bioresearch, biomarkers validation, and biodetection. Applied BioCode maintains an extensive collaborative network with universities, government laboratories, and industrial partners. This approach enables them to optimize efficiency and resources and leverage those to help its customers maximize the benefit of its powerful tools and collaborative networks.

Contacts

Applied BioCode, Inc.
Mr. Lance Hartel
Customer Solutions
562-801-0050

Contacts

Applied BioCode, Inc.
Mr. Lance Hartel
Customer Solutions
562-801-0050